Welcome: Noel O’Boyle
EMBL-EBI’s new Chemical Biology Resources Team Leader aims to encourage community engagement and explore AI-driven approaches.
PEOPLE & PERSPECTIVES2025
people-perspectivesperspectives
BioChemGraph: Unifying structural and bioactivity data to accelerate drug discovery
In the era of data-driven biology, integrating information from different resources is essential yet often challenging. The BioChemGraph project addresses this challenge by creating infrastructure that consolidates structural, functional, and biochemical annotations for small molecules and their…
2024
updates-from-data-resources
AI annotations increase patent data in SureCheMBL
AI annotations added to the SureChEMBL database increase the depth of data made available to users.
2024
sciencetechnology-and-innovation
EMBL-EBI databases considered critical to life sciences
Open data resources that enable global research and development recognised by the Global Biodata Coalition.
2022
announcementsscience
Repurposing drugs to manage COVID-19 progression
Researchers use large-scale human genetic studies to identify drug targets important for managing COVID-19 in its early stages
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Enzyme research made easier
Enzyme Portal makes it easier to explore all enzyme-related data in EMBL-EBI’s public resources.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
Open access drug discovery database launches with half a million compounds
ChEMBLdb, a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets, launches today with information on over half a million compounds. The data lie at the heart of translating information from the human genome into successful new…
SCIENCE & TECHNOLOGY2010
sciencescience-technology
No results found